date:Dec 12, 2018
cious use of antibiotics and that drug makers are developing alternatives.
Merck did not respond to a request for comment.
Elanco said a small portion of its portfolio includes medically important feed-grade antibiotics. The drugs are used to treat conditions such as liver abscesses and respiratory diseases, for which there are not effective alternatives, spokeswoman Colleen Parr Dekker said
It is important to ensure that policies do not move faster than science, she said.
Bob Smith, an Okla